ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVRO AVROBIO Inc

1.26
0.01 (0.80%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
AVROBIO Inc NASDAQ:AVRO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 0.80% 1.26 1.19 1.31 1.26 1.225 1.26 146,294 00:00:00

Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm

27/02/2024 3:50pm

PR Newswire (US)


AVROBIO (NASDAQ:AVRO)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more AVROBIO Charts.

NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Chord Energy Corporation (Nasdaq: CHRD) click to participate
    Chord Energy has agreed to merge with Enerplus Corporation. Under the agreement, shareholders of Enerplus will receive 0.10125 shares of Chord common stock and $1.84 per share in cash.
  • AVROBIO, Inc. (Nasdaq: AVRO) click to participate
    AVROBIO has agreed to merge with Tectonic Therapeutic. Under the agreement, current shareholders of AVROBIO are anticipated to hold about 22.3% of the merged entity. 
  • Kaman Corp. (NYSE: KAMN) click to participate
    Kaman has reached a deal to be quired by Arcline Investment Management, L.P. In this deal, each Kaman shareholder will be paid $46.00 per share in a cash transaction.
  • Catalent, Inc. (NYSE: CTLT) click to participate
    Novo Holdings has agreed to purchase Catalent. In accordance with the merger agreement, Catalent shareholders will receive $63.50 per share in cash.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605 
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-chrd-avro-kamn-and-ctlt-investors-to-contact-law-firm-302072856.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

1 Year AVROBIO Chart

1 Year AVROBIO Chart

1 Month AVROBIO Chart

1 Month AVROBIO Chart

Your Recent History

Delayed Upgrade Clock